Pfizer Said to Weigh Sale of Pump Unit Acquired in Hospira Deal

  • Drugmaker could fetch about $2 billion from transaction
  • Sale process is at very early stage, plans could change

Pfizer Inc. is weighing a sale of the pumps and devices business it acquired in last year’s purchase of Hospira Inc., people with knowledge of the matter said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.